CEDE Research
  • Home
  • About CEDE
  • Research Appointment Information
  • Current Research
  • About Research
    • Why Research?
    • What is Consent?
    • Research Resources
  • TrialNet
Type 1 Diabetes TrialNet (TrialNet) - CEDE does not participate in Trialnet, but we actively encourage families to consider enrolling is this study.  
Please visit TrialNet at www.diabetestrialnet.org
​
     TrialNet is an international network of researchers who are exploring ways to prevent, delay and reverse the progression of type 1 diabetes.  

     Studies are conducted in non-diabetic persons at risk of type 1 diabetes in an effort to delay the development of type 1 diabetes as a clinical disease; or (if initiated prior to appearance of autoimmunity) in an effort to delay the appearance of autoimmunity; or in individuals with type 1 diabetes who are either newly diagnosed or have evidence of sustained beta cell function.  Studies include long-term follow-up of subjects developing type 1 diabetes.
 The TrialNet network also supports natural history and genetics studies in populations screened for or enrolled in studies conducted by the TrialNet study group. In addition, TrialNet will evaluate methodologies that enhance the conduct of clinical trials interdicting the type 1 diabetes disease process.
​
​     



Powered by Create your own unique website with customizable templates.
  • Home
  • About CEDE
  • Research Appointment Information
  • Current Research
  • About Research
    • Why Research?
    • What is Consent?
    • Research Resources
  • TrialNet